Healthcare-pharma connect — a SaaS bridge between providers and pharma/biotech

Context

Healthcare providers and pharmaceutical / biotech / life-science companies need each other (providers to learn what is currently available for their patients, pharma to reach the clinicians who would use it), but most of the existing connection paths run through sales reps and conferences. The platform was a SaaS bridge sitting in between.

Problem

Industry-context data point: estimates suggest more than 90% of physicians are not fully aware of the latest pharma and device offerings relevant to their practice. That gap is not a marketing-attribution problem; it is an information-architecture problem, and a HIPAA-aware one, because the provider-side context carries protected health framing.

Approach

A SaaS build with a HIPAA-aware data posture from the outset, not retrofitted. The platform surfaces current pharma and device offerings on the provider side; the pharma side gets a structured channel into clinical workflows. The web-design layer matters because the audience is clinical, not consumer.

Solution

• SaaS platform build with provider-side and pharma-side surfaces.
• HIPAA-aware data handling baked into the architecture: access control, audit, retention, and storage decisions made with the compliance posture in mind.
• Provider-side discovery surface for pharma and device offerings.
• Pharma-side channel into the provider workflow.
• Web-design and IA tuned for a clinical audience.

Outcome

Above. The platform addresses a documented industry gap (the >90% awareness shortfall) with a SaaS connection model rather than a sales-rep channel.